SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010205
Filing Date
2020-08-10
Accepted
2020-08-10 16:31:41
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20200630x10q.htm   iXBRL 10-Q 2138891
2 EX-31.1 tmb-20200630xex31d1.htm EX-31.1 15444
3 EX-31.2 tmb-20200630xex31d2.htm EX-31.2 13513
4 EX-32.1 tmb-20200630xex32d1.htm EX-32.1 7642
5 EX-32.2 tmb-20200630xex32d2.htm EX-32.2 7020
  Complete submission text file 0001558370-20-010205.txt   6709580

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20200630.xsd EX-101.SCH 44144
7 EX-101.CAL tmb-20200630_cal.xml EX-101.CAL 45004
8 EX-101.DEF tmb-20200630_def.xml EX-101.DEF 187077
9 EX-101.LAB tmb-20200630_lab.xml EX-101.LAB 339412
10 EX-101.PRE tmb-20200630_pre.xml EX-101.PRE 306986
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20200630x10q_htm.xml XML 1119430
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 201089839
SIC: 2834 Pharmaceutical Preparations